Navigating Regional Differences in Accelerated Stability Conditions
Accelerated stability testing is a cornerstone of pharmaceutical development, offering predictive insights into a product’s shelf life within a compressed timeframe. However, global regulatory agencies like the FDA, EMA, ASEAN, and TGA apply distinct requirements regarding the conditions, duration, and interpretation of accelerated data. Navigating these regional differences is crucial to ensure your stability program…
Read More “Navigating Regional Differences in Accelerated Stability Conditions” »